News

Laureate Pharma (Laureate) and Iconic Therapeutics (Iconic) have completed the manufacturing of the first GMP lot of hI-con1, a recombinant Fc-Factor VII fusion protein. hI-con1 is a recombinant

BASF has named Stefan Beckmann as the head of the Care Chemicals and Formulators Europe unit. Dr. Beckmann has taken charge on January 1, 2010. He succeeds Friedrich

BioMimetic Therapeutics (BioMimetic) has amended and restated its manufacturing and supply agreement with Novartis Vaccines and Diagnostics, effective December 31, 2009, for the supply of bulk rhPDGF-BB The

Ceragenix has entered into an exclusive distribution and supply agreement with BioPro Pharmaceutical, to commercialize EpiCeram, a prescription topical cream for treating atopic dermatitis and other dry skin

Hari Kumar, chief business officer of Amira Pharmaceuticals, said: “Achieving this milestone further demonstrates the success of our partnership with GSK and provides a meaningful economic benefit to

Sciele Pharma has introduced Adrenaclick, a single-dose, epinephrine auto-injector, for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis. Adrenaclick is expected to be available

Watson Pharmaceuticals has confirmed that its subsidiary, Watson Laboratories has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market its 50mg, 100mg, 150mg,

The FDA has granted Orphan Drug Designation to Biovest International (Biovest) for its personalised lymphoma vaccine, BiovaxID. The company claims that BiovaxID represents a new class of active

Actavis has launched the antihypertensive drug ‘Losartan’ on day one, as the patent expired in Switzerland. The product was launched by the company under its own name, and